Savara Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
SVRA Company Description
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
SVRA Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SVRA Smart Score
Score Breakdown
SVRA Company Description
Show More
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of SVRA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SVRA's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on SVRA's company Twitter account
WallStreetBets
Number of mentions of SVRA in WallStreetBets Daily Discussion
SVRA News
Recent insights relating to SVRA
CNBC Recommendations
Recent picks made for SVRA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SVRA
Corporate Flights
Flights by private jets registered to SVRA
Our Analysis